539 related articles for article (PubMed ID: 17963849)
1. CGRP antagonists: unravelling the role of CGRP in migraine.
Doods H; Arndt K; Rudolf K; Just S
Trends Pharmacol Sci; 2007 Nov; 28(11):580-7. PubMed ID: 17963849
[TBL] [Abstract][Full Text] [Related]
2. Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine.
Rudolf K; Eberlein W; Engel W; Pieper H; Entzeroth M; Hallermayer G; Doods H
J Med Chem; 2005 Sep; 48(19):5921-31. PubMed ID: 16161996
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
[TBL] [Abstract][Full Text] [Related]
4. Examining the binding properties of MK-0974: a CGRP receptor antagonist for the acute treatment of migraine.
Moore EL; Burgey CS; Paone DV; Shaw AW; Tang YS; Kane SA; Salvatore CA
Eur J Pharmacol; 2009 Jan; 602(2-3):250-4. PubMed ID: 19084002
[TBL] [Abstract][Full Text] [Related]
5. [CGRP antagonists: novel concept for treatment of migraine].
Nieber K
Med Monatsschr Pharm; 2009 May; 32(5):182-5. PubMed ID: 19469188
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
Durham PL; Vause CV
CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
[TBL] [Abstract][Full Text] [Related]
7. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.
Villalón CM; Olesen J
Pharmacol Ther; 2009 Dec; 124(3):309-23. PubMed ID: 19796656
[TBL] [Abstract][Full Text] [Related]
8. Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.
Tfelt-Hansen PC
J Headache Pain; 2009 Dec; 10(6):389-91. PubMed ID: 19779958
[TBL] [Abstract][Full Text] [Related]
9. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
Link AS; Kuris A; Edvinsson L
J Headache Pain; 2008 Feb; 9(1):5-12. PubMed ID: 18217201
[TBL] [Abstract][Full Text] [Related]
10. The tortuous road to an ideal CGRP function blocker for the treatment of migraine.
Davis CD; Xu C
Curr Top Med Chem; 2008; 8(16):1468-79. PubMed ID: 18991732
[TBL] [Abstract][Full Text] [Related]
11. CGRP receptor antagonists: a new choice for acute treatment of migraine?
Durham PL
Curr Opin Investig Drugs; 2004 Jul; 5(7):731-5. PubMed ID: 15298069
[TBL] [Abstract][Full Text] [Related]
12. CGRP receptor antagonists: an expanding drug class for acute migraine?
Negro A; Lionetto L; Simmaco M; Martelletti P
Expert Opin Investig Drugs; 2012 Jun; 21(6):807-18. PubMed ID: 22512641
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide receptor antagonists for migraine.
Fischer MJ
Expert Opin Investig Drugs; 2010 Jul; 19(7):815-23. PubMed ID: 20482328
[TBL] [Abstract][Full Text] [Related]
14. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.
Tepper SJ; Cleves C
Curr Opin Investig Drugs; 2009 Jul; 10(7):711-20. PubMed ID: 19579177
[TBL] [Abstract][Full Text] [Related]
15. Targeting of calcitonin gene-related peptide action as a new strategy for migraine treatment.
Kuzawińska O; Lis K; Cessak G; Mirowska-Guzel D; Bałkowiec-Iskra E
Neurol Neurochir Pol; 2016; 50(6):463-467. PubMed ID: 27553188
[TBL] [Abstract][Full Text] [Related]
16. Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
Tepper SJ; Stillman MJ
Headache; 2008 Sep; 48(8):1259-68. PubMed ID: 18808506
[TBL] [Abstract][Full Text] [Related]
17. CGRP receptor antagonism and migraine therapy.
Edvinsson L; Warfvinge K
Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
[TBL] [Abstract][Full Text] [Related]
18. CGRP antagonists: hope for a new era in acute migraine treatment.
Schelstraete C; Paemeleire K
Acta Neurol Belg; 2009 Dec; 109(4):252-61. PubMed ID: 20120204
[TBL] [Abstract][Full Text] [Related]
19. CGRP receptors in the control of pain and inflammation.
Benemei S; Nicoletti P; Capone JG; Geppetti P
Curr Opin Pharmacol; 2009 Feb; 9(1):9-14. PubMed ID: 19157980
[TBL] [Abstract][Full Text] [Related]
20. CGRP receptor antagonism and migraine.
Edvinsson L; Ho TW
Neurotherapeutics; 2010 Apr; 7(2):164-75. PubMed ID: 20430315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
